兴齐眼药股价涨5.1%，南方基金旗下1只基金位居十大流通股东，持有251.63万股浮盈赚取842.97万元

Core Insights - On October 15, Xingqi Eye Pharmaceutical Co., Ltd. saw a stock price increase of 5.1%, reaching 69.02 CNY per share, with a trading volume of 390 million CNY and a turnover rate of 3.08%, resulting in a total market capitalization of 16.934 billion CNY [1] Company Overview - Xingqi Eye Pharmaceutical, established on March 24, 1977, and listed on December 8, 2016, is located in Shenyang, Liaoning Province. The company specializes in the research, production, and sales of ophthalmic drugs [1] - The revenue composition of the company includes eye drops at 82.15%, gel/ointment at 16.70%, and other supplementary products at 1.15% [1] Shareholder Insights - Southern Fund's Southern CSI 500 ETF (510500) is among the top ten circulating shareholders of Xingqi Eye Pharmaceutical, having increased its holdings by 764,100 shares in the second quarter, totaling 2.5163 million shares, which represents 1.34% of the circulating shares. The estimated floating profit today is approximately 8.4297 million CNY [2] - The Southern CSI 500 ETF was established on February 6, 2013, with a current scale of 113.438 billion CNY. Year-to-date returns stand at 27.41%, ranking 1733 out of 4220 in its category, while the one-year return is 30.04%, ranking 1557 out of 3857. Since inception, the fund has achieved a return of 141.75% [2] Fund Performance - The fund manager of Southern CSI 500 ETF is Luo Wenjie, who has a tenure of 12 years and 180 days. The total asset scale under his management is 138.999 billion CNY, with the best fund return during his tenure being 152.82% and the worst being -47.6% [3] - Another fund, Southern Big Data 300 Index A (001420), also holds a significant position in Xingqi Eye Pharmaceutical, with 47,800 shares, accounting for 0.93% of the fund's net value. The estimated floating profit today is around 160,000 CNY [4] - The Southern Big Data 300 Index A was established on June 24, 2015, with a current scale of 2.17 billion CNY. Year-to-date returns are 37.99%, ranking 973 out of 4220, while the one-year return is 51.94%, ranking 473 out of 3857. Since inception, the fund has achieved a return of 83.07% [4] Additional Fund Management Insights - The fund manager of Southern Big Data 300 Index A is Xie Rui, who has a tenure of 3 years and 241 days. The total asset scale under his management is 2.012 billion CNY, with the best fund return during his tenure being 24.17% and the worst being -0.02% [5]